Trial reportScientific reports2026
Longitudinal proteomic analysis of GCF in regenerative healing of molar furcation degree II defects treated with OFD, EMD, or A-PRF + : a pilot study.
Trial report in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study evaluated associations between protein expression and postoperative healing scores following three periodontal regenerative procedures (Open Flap Debridement-OFD, Enamel Matrix Derivative-EMD, Advanced Platelet Rich Fibrin-A-PRF +) in molar degree II furcations over six months. Associations between baseline systemic biochemical parameters and six-month clinical outcomes were also assessed. Eighteen patients were randomly assigned to control (OFD), EMD, or A-PRF + groups. Baseline plasma biomarkers were modeled on probing depth (PD), clinical attachment level (CAL), and alveolar bone level (ABL) at six months. Gingival crevicular fluid (GCF) samples were analyzed using the Olink® Target 96 Immuno-Oncology panel at day 3, weeks 1, 2, 6, and months 3 and 6. Multivariable linear regressions identified proteins associated with the modified Early Wound Healing Index (mEHI) per treatment. Seventeen patients completed follow-up. HDL- and LDL-cholesterol and creatinine were negatively associated with PD, CAL, and ABL improvements (p < 0.05). At early timepoints, CASP-8, IL-8, and LAP TGF-β1 showed stronger associations with mEHI in A-PRF + than OFD or EMD, while ARG-1 and TRAIL demonstrated treatment-specific patterns over time. No differences were observed at month 6. High baseline cholesterol and creatinine may impair periodontal regeneration. Distinct proteomic signatures suggest differential biological pathways underlying healing across OFD, EMD, and A-PRF + procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.